Differential Role of Serotonergic Projections Arising from the Dorsal and Median Raphe Nuclei in Locomotor Hyperactivity and Prepulse Inhibition

Neuropsychopharmacology

Volumn 28, Issue 12, 2003, Pages 2138-2147

  Kusljic, Snezana ^a,b   Copolov, David L ^a   Van Den Buuse, Maarten ^a,b  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

5,7 dihydroxytryptamine; Amphetamine; Immunohistochemistry; Phencyclidine; Prepulse inhibition; Schizophrenia; Serotonin

Indexed keywords

5,7 DIHYDROXYTRYPTAMINE; DESIPRAMINE; DEXAMPHETAMINE; NEUROTOXIN; PHENCYCLIDINE; PSYCHOTROPIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; DISEASE SIMULATION; DORSAL RAPHE NUCLEUS; HISTOPATHOLOGY; HYPERACTIVITY; LOCOMOTION; MALE; MEDIAN RAPHE NUCLEUS; MICROINJECTION; NONHUMAN; PATHOPHYSIOLOGY; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; RAT STRAIN; SCHIZOPHRENIA; SEROTONIN RELEASE; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM; STEREOTAXIC SURGERY;

EID: 0344552961     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300277     Document Type: Article

References (63)

1. Abi-Dargham A, Laruelle M, Aghajanian GK, Charney D, Krystal J (1997). The role of serotonin in the pathophysiology and treatment of schizophrenia. J Neuropsychol Clin Neurosci 9: 1-17.
2. Adell A, Myers RD (1995). Selective destruction of midbrain raphe nuclei by 5,7-DHT: is brain 5-HT involved in alcohol drinking in Sprague-Dawley rats? Brain Res 693: 70-79.
3. Albinsson A, Andersson G, Andersson K, Vega-Matuszczyk J, Larsson K (1996). The effects of lesions in the mesencephalic raphe systems on male rat sexual behavior and locomotor activity. Behav Brain Res 80: 57-63.
4. Andrade TG, Graeff FG (2001). Effect of electrolytic and neurotoxic lesions of the median raphe nucleus on anxiety and stress. Pharmacol Biochem Behav 70: 1-14.
5. Asin KE, Fibiger HC (1983). An analysis of neuronal elements within the median nucleus of the raphe that mediate lesion-induced increases in locomotor activity. Brain Res 268: 211-223.
6. Azmitia EC, Whitaker-Azmitia PM (1995). Anatomy, cell biology, and plasticity of the serotonergic system. Neuropsychopharmacological implications for the actions of psychotropic drugs. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: The Fourth Generation of Progress. Raven Press: New York. pp 443-449.
7. Braff D, Geyer M (1989). Sensorimotor gating and the neurobiology of schizophrenia: human and animal model studies. In: Schulz S, Tamminga C (eds) Schizophrenia: Scientific Progress. Oxford University Press: Oxford. pp 124-137.
8. Carlsson A, Lindqvist M (1963). Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol 20: 140-144.
9. Carlsson A, Waters N, Holm-Waters S, Tedroff J, Nilsson M, Carlsson ML (2001). Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol 41: 237-260.
10. Contreras PC, Monahan JB, Lanthorn TH, Pullan LM, DiMaggio DA, Handelmann GE et al (1987). Phencyclidine. Physiological actions, interactions with excitatory amino acids and endogenous ligands. Mol Neurobiol 1: 191-211.
11. Davis M, Gendelman DS, Tischler MD, Gendelman PM (1982). A primary acoustic startle circuit: lesion and stimulation studies. J Neurosci 2: 791-805.
12. Davis M, Sheard MH (1974). Habituation and sensitization of the rat startle response: effects of raphe lesions. Physiol Behav 12: 425-431.
13. Davis M, Strachan DI, Kass E (1980). Excitatory and inhibitory effects of serotonin on sensorimotor reactivity measured with acoustic startle. Science 209: 521-523.
14. Dean B (2000). Signal transmission, rather than reception, is the underlying neurochemical abnormality in schizophrenia. Aust NZ J Psychiatry 34: 560-569.
15. Drevets WC, Gautier C, Price JC, Kupfer DJ, Kinahan PE, Grace AA et al (2001). Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol Psychiatry 49: 81-96.
16. Duncan EJ, Madonick SH, Parwani A, Angrist B, Rajan R, Chakravorty S et al (2001). Clinical and sensorimotor gating effects of ketamine in normals. Neuropsychopharmacology 25: 72-83.
17. File SE, Deakin JF (1980). Chemical lesions of both dorsal and median raphe nuclei and changes in social and aggressive behaviour in rats. Pharmacol Biochem Behav 12: 855-859.
18. Fletcher PJ, Selhi ZF, Azampanah A, Sills TL (2001). Reduced brain serotonin activity disrupts prepulse inhibition of the acoustic startle reflex. Effects of 5,7-dihydroxytryptamine and p-chlorophenylalanine. Neuropsychopharmacology 24: 399-409.
19. Gately PF, Poon SL, Segal DS, Geyer MA (1985). Depletion of brain serotonin by 5,7-dihydroxytryptamine alters the response to amphetamine and the habituation of locomotor activity in rats. Psychopharmacology 87: 400-405.
20. Gately PF, Segal DS, Geyer MA (1986). The behavioral effects of depletions of brain serotonin induced by 5,7-dihydroxytryptamine vary with time after administration. Behav Neural Biol 45: 31-42.
21. Geyer MA (1998). Behavioral studies of hallucinogenic drugs in animals: implications for schizophrenia research. Pharmacopsychiatry 31(Suppl 2): 73-79.
22. Geyer MA, Markou A (1995). Animal models of psychiatric disorders. In: Bloom F, Kupfer D (eds) Psychopharmacology: The Fourth Generation of Progress. Raven Press: New York. pp 787-798.
23. Geyer MA, Swerdlow NR, Mansbach RS, Braff DL (1990). Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res Bull 25: 485-498.
24. Gleason SD, Shannon HE (1997). Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice. Psychopharmacology (Berl) 129: 79-84.
25. Gogos A, Van den Buuse M (2000). Role of brain serotonin in schizophrenia: behavioural effect of dorsal raphe nucleus lesions in rats. Proc Aust Soc Clin Exp Pharmacol Toxicol 8: 87.
26. Grace AA (1995). The tonic/phasic model of dopamine system regulation: its relevance for understanding how stimulant abuse can alter basal ganglia function. Drug Alcohol Depen 37: 111-129.
27. Harrison PJ (1999). The neuropathology of schizophrenia. Brain 122: 593-624.
28. 1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia. Life Sci 48: 355-363.
29. 2C/2B receptor antagonists: neurochemical and behavioural studies. Neuropharmacology 39: 2318-2328.
30. Jacobs BL, Wise WD, Taylor KM (1974). Differential behavioral and neurochemical effects following lesions of the dorsal or median raphe nuclei in rats. Brain Res 79: 353-361.
31. Javitt DC, Zukin SR (1991). Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148: 1301-1308.
32. Jentsch JD, Tran A, Taylor JR, Roth RH (1998). Prefrontal cortical involvement in phencyclidine-induced activation of the mesolimbic dopamine system: behavioral and neurochemical evidence. Psychopharmacology (Berl) 138: 89-95.
33. Jonsson G (1980). Chemical neurotoxins as denervation tools in neurobiology. Ann Rev Neurosci 3: 169-187.
34. Josselyn SA, Miller R, Beninger RJ (1997). Behavioral effects of clozapine and dopamine receptor subtypes. Neurosci Biobehav Rev 21: 531-558.
35. Kapur S, Remington G (1996). Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry 153: 466-476.
36. Kelly PH, Seviour PW, Iversen SD (1975). Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 94: 507-522.
37. Koch M, Schnitzler HU (1997). The acoustic startle response in rats - circuits mediating evocation, inhibition and potentiation. Behav Brain Res 89: 35-49.
38. Kretschmer BD, Koch M (1998). The ventral pallidum mediates disruption of prepulse inhibition of the acoustic startle response induced by dopamine agonists, but not by NMDA antagonists. Brain Res 798: 204-210.
39. Kuczenski R, Segal DS, Cho AK, Melega W (1995). Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine. J Neurosci 15: 1308-1317.
40. Laruelle M, Abi-Dargham A, Casanova MF, Toti R, Weinberger DR, Kleinman JE (1993). Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study. Arch Gen Psychiatry 50: 810-818.
41. Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D'Souza CD, Erdos J et al (1996). Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA 93: 9235-9240.
42. Legutko R, Gannon RL (2001). Serotonin transporter localization in the hamster suprachiasmatic nucleus. Brain Res 893: 77-83.
43. Martin P, Carlsson ML, Hjorth S (1998a). Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats. Neuroreport 9: 2985-2988.
44. 2A receptor antagonism is dependent on increased serotonergic tone. J Neural Transm 105: 365-396.
45. McQuade R, Sharp T (1997). Functional mapping of dorsal and median raphe 5-hydroxytryptamine pathways in forebrain of the rat using microdialysis. J Neurochem 69: 791-796.
46. Meltzer HY (1989). Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology (Berl) 99(Suppl): S18-S27.
47. Meltzer HY (1995). The role of serotonin in schizophrenia and the place of serotonin-dopamine antagonist antipsychotics. J Clin Psychopharmacol 15: 2S-3S.
48. Mokler DJ, Lariviere D, Johnson DW, Theriault NL, Bronzino JD, Dixon M et al (1998). Serotonin neuronal release from dorsal hippocampus following electrical stimulation of the dorsal and median raphe nuclei in conscious rats. Hippocampus 8: 262-273.
49. Moore H, West AR, Grace AA (1999). The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia. Biol Psychiatry 46: 40-55.
50. Paxinos G, Watson C (1998). The Rat Brain in Stereotaxic Co-Ordinates 4th edn Academic press: New York.
51. Pradhan SN (1984). Phencyclidine (PCP): some human studies. Neurosci Biobehav Rev 8: 493-501.
52. Prinssen EP, Assie MB, Koek W, Kleven MS (2002). Depletion of 5-HT disrupts prepulse inhibition in rats. Dependence on the magnitude of depletion, and reversal by a 5-HT precursor. Neuropsychopharmacology 26: 340-347.
53. Rossum V (1966). The significance of dopamine receptor blockade for the mechanism of action of neuroleptic drugs. Arch Int Pharmacodyn Ther 160: 492-494.
54. Roth BL, Meltzer HY (1995). The role of serotonin in schizophrenia. In: Bloom F, Kupfer D (eds) Psychopharmacology: The Fourth Generation of Progress. Raven Press: New York. pp 1215-1227.
55. Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI et al (2001). Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39: 32-41.
56. Sams-Dodd F (1998). A test of the predictive validity of animal models of schizophrenia based on phencyclidine and D-amphetamine. Neuropsychopharmacology 18: 293-304.
57. Seiden LS, Sabol KE, Ricaurte GA (1993). Amphetamine: effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol 33: 639-677.
58. Swerdlow NR, Geyer MA (1998). Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull 24: 285-301.
59. Swerdlow NR, Keith VA, Braff DL, Geyer MA (1991). Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat. J Pharmacol Exp Ther 256: 530-536.
60. Thomas H, Fink H, Sohr TR, Voits M (2000). Lesion of the median raphe nucleus: a combined behavioral and microdialysis study in rats. Pharmacol Biochem Behav 65: 15-21.
61. Van den Buuse M (2003). Deficient prepulse inhibition of acoustic startle in Hooded-Wistar rats compared with Sprague-Dawley rats. Clin Exp Pharmacol Physiol 30: 254-261.
62. Van den Buuse M, Eikelis N (2001). Estrogen increases prepulse inhibition of acoustic startle in rats. Eur J Pharmacol 425: 33-41.
63. Velakoulis D, Pantelis C, McGorry PD, Dudgeon P, Brewer W, Cook M et al (1999). Hippocampal volume in first-episode psychoses and chronic schizophrenia: a high-resolution magnetic resonance imaging study. Arch Gen Psychiatry 56: 133-141.